CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,097,612 | -8.7% | 274,869 | +1.1% | 0.01% | -10.0% |
| Q2 2023 | $8,868,203 | +97160.4% | 271,864 | +4.9% | 0.01% | -9.1% |
| Q1 2023 | $9,118 | -19.6% | 259,098 | +4.7% | 0.01% | -26.7% |
| Q4 2022 | $11,339 | -99.9% | 247,458 | +3.1% | 0.02% | -11.8% |
| Q3 2022 | $11,627,000 | +35.8% | 239,972 | +10.2% | 0.02% | +41.7% |
| Q2 2022 | $8,559,000 | +15.1% | 217,848 | +7.8% | 0.01% | +20.0% |
| Q1 2022 | $7,438,000 | -13.0% | 202,073 | +7.8% | 0.01% | 0.0% |
| Q4 2021 | $8,547,000 | +27.9% | 187,521 | +0.3% | 0.01% | +11.1% |
| Q3 2021 | $6,683,000 | +72.6% | 186,996 | -4.4% | 0.01% | +80.0% |
| Q2 2021 | $3,871,000 | -18.1% | 195,601 | -3.7% | 0.01% | -16.7% |
| Q1 2021 | $4,727,000 | +14.5% | 203,217 | +2.3% | 0.01% | 0.0% |
| Q4 2020 | $4,129,000 | +2.3% | 198,679 | +6.5% | 0.01% | 0.0% |
| Q3 2020 | $4,038,000 | -1.7% | 186,504 | +7.0% | 0.01% | -14.3% |
| Q2 2020 | $4,109,000 | +92.9% | 174,319 | -3.5% | 0.01% | +75.0% |
| Q1 2020 | $2,130,000 | +13.3% | 180,633 | +1.9% | 0.00% | +33.3% |
| Q4 2019 | $1,880,000 | -0.5% | 177,227 | +6.8% | 0.00% | 0.0% |
| Q3 2019 | $1,889,000 | +4.5% | 166,002 | +3.3% | 0.00% | 0.0% |
| Q2 2019 | $1,808,000 | +51.9% | 160,708 | +9.3% | 0.00% | +50.0% |
| Q1 2019 | $1,190,000 | +27.1% | 147,057 | -0.7% | 0.00% | 0.0% |
| Q4 2018 | $936,000 | -23.3% | 148,034 | +19.5% | 0.00% | 0.0% |
| Q3 2018 | $1,220,000 | +22.6% | 123,865 | +3.4% | 0.00% | 0.0% |
| Q2 2018 | $995,000 | +25.8% | 119,830 | +9.0% | 0.00% | 0.0% |
| Q1 2018 | $791,000 | -8.0% | 109,912 | +4.2% | 0.00% | 0.0% |
| Q4 2017 | $860,000 | -32.7% | 105,520 | +19.8% | 0.00% | -33.3% |
| Q3 2017 | $1,277,000 | +27.8% | 88,056 | +6.6% | 0.00% | +50.0% |
| Q2 2017 | $999,000 | +98.6% | 82,586 | +111.1% | 0.00% | +100.0% |
| Q1 2017 | $503,000 | +8.9% | 39,130 | +3.0% | 0.00% | 0.0% |
| Q4 2016 | $462,000 | +44.4% | 37,997 | +9.1% | 0.00% | 0.0% |
| Q3 2016 | $320,000 | -17.1% | 34,835 | -14.4% | 0.00% | 0.0% |
| Q2 2016 | $386,000 | +26.6% | 40,695 | -5.8% | 0.00% | 0.0% |
| Q1 2016 | $305,000 | -28.2% | 43,196 | +6.4% | 0.00% | 0.0% |
| Q4 2015 | $425,000 | +59.2% | 40,616 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $267,000 | +4.3% | 39,896 | +4.8% | 0.00% | 0.0% |
| Q2 2015 | $256,000 | -19.0% | 38,065 | -18.4% | 0.00% | 0.0% |
| Q1 2015 | $316,000 | -12.9% | 46,630 | +2.9% | 0.00% | 0.0% |
| Q4 2014 | $363,000 | +150.3% | 45,330 | +9.9% | 0.00% | – |
| Q3 2014 | $145,000 | -26.4% | 41,230 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $197,000 | +35.9% | 41,230 | +170.8% | 0.00% | – |
| Q1 2014 | $145,000 | +95.9% | 15,227 | +33.8% | 0.00% | – |
| Q4 2013 | $74,000 | -5.1% | 11,377 | +10.7% | 0.00% | – |
| Q3 2013 | $78,000 | -35.5% | 10,277 | -2.1% | 0.00% | – |
| Q2 2013 | $121,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |